1. Home
  2. KWR vs SUPN Comparison

KWR vs SUPN Comparison

Compare KWR & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KWR

Quaker Houghton

HOLD

Current Price

$151.15

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$46.34

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KWR
SUPN
Founded
1918
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
1994
2010

Fundamental Metrics

Financial Performance
Metric
KWR
SUPN
Price
$151.15
$46.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$167.00
$61.60
AVG Volume (30 Days)
141.5K
854.3K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
1.52%
N/A
EPS Growth
N/A
N/A
EPS
1.13
N/A
Revenue
$1,888,634,000.00
$392,755,000.00
Revenue This Year
$5.16
$22.70
Revenue Next Year
$3.63
$19.14
P/E Ratio
$131.70
N/A
Revenue Growth
2.66
N/A
52 Week Low
$111.42
$32.83
52 Week High
$183.01
$59.68

Technical Indicators

Market Signals
Indicator
KWR
SUPN
Relative Strength Index (RSI) 51.24 45.67
Support Level $146.59 $43.43
Resistance Level $155.88 $46.79
Average True Range (ATR) 5.32 1.65
MACD -0.58 -0.16
Stochastic Oscillator 63.41 4.62

Price Performance

Historical Comparison
KWR
SUPN

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The company's product portfolio includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. The company's geographic segments include the Americas, EMEA, and Asia/Pacific. The majority of the company's revenue is earned from the Americas.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: